Computational drug design of novel COVID-19 inhibitor

Computational drug design of novel COVID-19 inhibitor

Abstract Background In 2003, the first case of severe acute respiratory syndrome coronavirus (SARS-CoV) was recorded. Coronaviruses (CoVs) have caused a major outbreak of human fatal pneumonia. Currently, there is no specific drug or treatment for diseases caused by SARS CoV 2. Computational approac...

Full description

Bibliographic Details
Main Authors: David Ebuka Arthur, Benjamin Osebi Elegbe, Augustina Oyibo Aroh, Mahmoud Soliman
Format: Article
Language:English
Published: SpringerOpen 2022-07-01
Series:Bulletin of the National Research Centre
Subjects:
Binding energy
Covid-19
HIV-1 inhibitors
Molecular docking
SBDD
Online Access:https://doi.org/10.1186/s42269-022-00892-z

Internet

https://doi.org/10.1186/s42269-022-00892-z

Similar Items